30 May 2022 Embargo: Immediate release Pretoria, 30 May 2022 - The use of Ivermectin for the treatment and prevention of COVID-19 received a lot of public interest in 2020. Early evidence, mostly from studies with a small number of patients and conducted with varying degrees...
27 May 2022 Embargo: Immediate release On 7 May 2022, the South African Health Products Regulatory Authority (SAHPRA) published a statement indicating that it would join the Minister of Health in approaching the Constitutional Court for leave to appeal the Supreme Court of Appeal (SCA) judgement...
12 May 2022Embargo: Immediate release In both the United States and South Africa, the COVID-19 Vaccine Janssen has been approved as a single primary vaccination dose, a single booster dose at least two months after the primary vaccination dose, and as a heterologous booster dose following...
EKATERINA BOLOVTSOVA via Pexels...
03 May 2022 Embargo: Immediate release Pretoria, 3 May 2022 - In October 2021, the African Christian Democratic Party (ACDP); Free the Children -Save the Nation NPC, Caring Healthcare Workers Coalition NPC, and the COVID Care Alliance NPC initiated court action against the Minister of Health and...
20 April 2022 Embargo: Immediate release The South Africa Health Products Regulatory Authority (SAHPRA) notes the ruling by the Supreme Court of Appeal (SCA) in favour of the Alliance of Natural Health Products in South Africa (ANHP) on 11 April 2022. SAHPRA is studying this judgement and consulting...
08 April 2022 Embargo: Immediate release The South Africa Health Products Regulatory Authority (SAHPRA) remains committed in protecting the public from the supply of counterfeit and substandard medicines. Following the media report by eNCA claiming that some hawkers in Cape Town were illegally selling medicines, SAHPRA worked...
11 March 2022 Embargo: Immediate release The South Africa Health Products Regulatory Authority (SAHPRA) has noted that a safety report in relation to the COVID-19 Pfizer Comirnaty vaccine directed to the United States Food and Drug Administration (FDA) has been distributed on various communication platforms in South...
23 December 2021 Embargo: Immediate release The South African Health Products Regulatory Authority (SAHPRA) initially registered the COVID-19 Vaccine Janssen, with conditions on 30 March 2021, in terms of section 15 of the Medicines and Related Substance Act (Act 101 of 1965). On 10 December 2021, SAHPRA received...
8 December 2021 Embargo: Immediate release The South African Health Products Authority (SAHPRA) initially approved the use of Pfizer’s Comirnaty® COVID-19 vaccine on 16 March 2021, in terms of section 21 of the Medicines and Related Substance Act (Act 101 of 1965). On 17 November 2021, SAHPRA received...
